Amiodarone-induced Pulmonary Inflammation: Correlation with Drug Dose and Lung Levels of Drug, Metabolite, and Phospholipid
- 1 May 1991
- journal article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 143 (5) , 1110-1114
- https://doi.org/10.1164/ajrccm/143.5_pt_1.1110
Abstract
To investigate the hypotheses that amiodarone-induced pulmonary inflammation may be related to direct drug toxicity, groups of 10 or more Wistar rats were fed amiodarone by gavage at concentrations of 175, 300, 400, and 500 mg/kg/day, or vehicle alone. After 6 wk of drug feeding, the rats were examined for histologic and cellular evidence of pulmonary inflammation. In addition, the amounts of amiodarone, the major metabolite of amiodarone N-desethylamiodarone (N-des), and phospholipid in the lungs were determined. We found that rats fed 175 mg/kg of amiodarone were essentially no different from control animals. The 175 mg/kg group had normal lung histologies, no change in lavage cell counts or differential counts, and very little amiodarone, N-des, or phospholipid in the lungs. In contrast, the three high-dose groups had abnormal lung histologies along with increases in lavage cell counts and change in differential counts. There were also significant increases in the amounts of amiodarone, N-des, and phospholipid in the lung. We conclude that the development of amiodarone-induced pulmonary inflammation is dose dependent, and that there is a direct correlation between the amount of amiodarone, N-des, and phospholipid in the lung with the development of inflammation. It therefore appears that the drug is directly toxic to lung tissue.Keywords
This publication has 9 references indexed in Scilit:
- Amiodarone-induced pulmonary toxicity in the ratLung, 1989
- Anti-amiodarone antibodies: Detection and relationship to the development of side effectsThe American Journal of Medicine, 1988
- Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effectsThe American Journal of Medicine, 1987
- Bronchoalveolar Lavage in Amiodarone PneumonitisChest, 1987
- Role of phospholipase A inhibition in amiodarone pulmonary toxicity in ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Side effects and possible contraindications of amiodarone useAmerican Heart Journal, 1983
- Adverse reactions during treatment with amiodarone hydrochloride.BMJ, 1983
- Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.Circulation, 1983
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983